Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4692)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 20, 2023 (publication date) through Sep 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Methodology
ISSN
2222-0682
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tamura H. IgA nephropathy associated with Crohn's disease. World J Methodol 2023; 13(3): 67-78 [PMID: 37456980 DOI: 10.5662/wjm.v13.i3.67] |
|---|---|
| URL: | https://www.wjgnet.com/2222-0682/full/v13/i3/67.htm |
| Number | Citing Articles |
| 1 |
Krzysztof Skoczyński, Jan Koziej, Sylwia Szymańska, Łukasz Obrycki, Ryszard Grenda, Mieczysław Litwin. Adalimumab as a cause of kidney injury in patients with Crohn’s disease. Pediatric Nephrology 2024; 39(8): 2359 doi: 10.1007/s00467-024-06338-0
|
| 2 |
Charlotte Larson, Naim Munir, Panduranga Rao, Evan Farkash, Priya Kathuria, Dustin Romain, Jeffery Berinstein. Crohn's Disease Associated With IgA Nephropathy Effectively Treated With the Interleukin-23 Inhibitor Risankizumab. ACG Case Reports Journal 2024; 11(7): e01437 doi: 10.14309/crj.0000000000001437
|